Samtec Biotecnologia

What Samtec Biotecnologia does

Samtec Biotecnologia LTDA is a privately-held Brazilian pharmaceutical manufacturer founded in 2002, headquartered in Ribeirão Preto, São Paulo. The company specializes in Small Volume Parenteral Solutions (Soluções Parenterais de Pequeno Volume) packaged in plastic ampoules — a niche in which it self-identifies as the Brazilian market leader. Its product portfolio spans electrolyte replacement solutions (sodium chloride at 0.9%, 10%, and 20%; potassium chloride at 10%, 15%, and 19.1%; sodium bicarbonate at 8.4%; magnesium sulfate at 10% and 50%), hypertonic glucose solutions (25% and 50%), and sterile apyrogenic water for injection, offered in 5mL, 10mL, and 20mL formats and sold in standardized boxes of 200 plastic ampoules. The portfolio is split into two lines: the B2B Hospital Line (Linha Hospitalar) targeting hospitals and clinics, and a consumer-facing Pharma Line (Linha Farma) anchored by Solusam, a 0.9% sodium chloride 5mL saline solution for nasal hygiene.

Manufacturing is conducted at the Ribeirão Preto facility using automated, continuously validated production lines governed by a comprehensive Quality Management System compliant with ANVISA and international quality standards. A validated workforce training program ensures consistent operational competency across production and quality functions. Distribution is national, covering all 26 Brazilian states and the Federal District, executed through direct B2B sales to hospitals and clinics, wholesale distribution to pharmacies and drugstores, and an online client portal (Espaço do Cliente) that supports ordering and access to technical documentation. Consumer engagement is supported by a SAC (Serviço de Atendimento ao Consumidor) channel, downloadable product leaflets (bulas), and health-related informational content on the corporate website.

Revenue is generated through hardware-style sales of sterile injectable pharmaceuticals, with no public pricing disclosed and pricing likely subject to ANVISA regulation and government procurement frameworks. The company employs 51-100 people, operates as a founder/owner-managed limited liability company (LTDA), and has no disclosed external investors, parent company, M&A activity, or funding rounds. Its only documented partnership is a minor cloud infrastructure arrangement with Linode for website hosting. No AI/ML capabilities, patents, or trademarks are disclosed.

Name

Samtec Biotecnologia

Legal name

Samtec Biotecnologia LTDA

Website

https://samtec.com.br

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Samtec Biotecnologia is a Brazilian pharmaceutical manufacturer founded in 2002, producing sterile Small Volume Parenteral Solutions in plastic ampoules — including saline, glucose, and electrolyte replacements — for hospitals, clinics, and pharmacies across all 26 Brazilian states and the Federal District.

Ownership category

akta.pro rank

Product category

Parenteral Solutions Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro industry

PRIMARYHLAIABAL

Generic Hospital & Institutional Products

Healthcare & Life Sciences/Pharmaceuticals/Generic Pharmaceuticals

SECONDARYIMALAIAA

Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules)

Industrials, Manufacturing & Construction/Packaging & Containers/Pharmaceutical & Medical Packaging

SECONDARYIMALAIAE

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges)

Industrials, Manufacturing & Construction/Packaging & Containers/Pharmaceutical & Medical Packaging

Keywords

• Parenteral solutions
• Injectable pharmaceuticals
• Small volume parenterals
• Electrolyte solutions
• Plastic ampoules

Headquarters

HQ city

Ribeirão Prêto

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Injectables Sales: Manufacturing and sale of injectable pharmaceutical products (parenteral solutions) including sodium chloride, glucose, potassium chloride, sodium bicarbonate, magnesium sulfate, and water for injection in plastic ampoules. Products are sold to healthcare institutions, hospitals, pharmacies, and medical professionals across Brazil.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Samtec Biotecnologia manufactures small volume parenteral (SVP) injectable pharmaceutical solutions packaged in plastic ampoules, including sodium chloride, glucose, potassium chloride, sodium bicarbonate, magnesium sulfate, and water for injection. The company produces two main lines: the Hospital Line (Linha Hospitalar) sold to healthcare institutions and hospitals, and the Pharma Line (Linha Farma) distributed through pharmacies and drugstores, with consumer products such as Solusam 0.9% sodium chloride 5mL.

Product overview

Samtec Biotecnologia is a Brazilian pharmaceutical company specializing in the manufacturing of small-volume parenteral injectable medications in plastic ampules. The company operates two main product lines: Linha Hospitalar (Hospital Line) and Linha Farma (Pharma Line). The Hospital Line includes a comprehensive portfolio of electrolyte replacement solutions (sodium chloride, potassium chloride, magnesium sulfate, sodium bicarbonate), glucose solutions, and sterile water for injection available in multiple concentrations and volumes (5mL, 10mL, 20mL). The Pharma Line features Solusam (0.9% Sodium Chloride Solution 5mL). All products are manufactured in plastic ampules and sold in boxes of 200 units. Samtec is the Brazilian market leader in small-volume parenteral solutions and maintains a strong presence across all 26 Brazilian states and the Federal District.

Differentiator

Problem solved

Functional benefit

Products and services

• Linha Hospitalar (Hospital Line) A product line of injectable small volume parenteral solutions designed for healthcare institutions and hospitals, covering electrolyte, glucose, and water for injection presentations in plastic ampoules.
• Linha Farma (Pharma Line)

Quantifiable outcome

• Leader in Brazilian Small Volume Parenteral Solutions market in plastic ampoules
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Cristália Produtos Químicos Farmacêuticos: Brazilian pharmaceutical manufacturer headquartered in São Paulo state with a strong focus on injectable hospital products, anesthetics, and small-volume parenterals — directly comparable to Samtec's SVP plastic ampoule portfolio and Brazilian hospital B2B channel.
• Halex Istar Indústria Farmacêutica: One of Brazil's leading manufacturers of large- and small-volume parenteral solutions, electrolytes, and irrigation fluids. Halex Istar is the most direct domestic competitor to Samtec in SVP injectables serving Brazilian hospitals.
• Hipolabor Farmacêutica: Brazilian generic pharmaceutical manufacturer with a hospital-focused injectables line. Closely comparable to Samtec in product mix (basic injectables, electrolytes), scale, and B2B/B2G distribution model.

Broad incumbents

• Fresenius Kabi (Brazil): Global leader in clinical nutrition, IV drugs, and medical devices with extensive Brazilian operations. Overlaps directly with Samtec's SVP electrolyte and injection portfolio while offering broader hospital channel depth and global scale.
• B. Braun (Brazil): German-headquartered medical device and parenteral solutions manufacturer with a substantial Brazilian footprint. Competes with Samtec in SVP injectable solutions and brings global regulatory strength and broader hospital formulary contracts.
• Eurofarma Laboratórios: One of the largest Brazilian pharmaceutical groups, with a generics and injectables portfolio spanning hospitals and retail. Comparable in customer base (B2B hospitals and pharmacies) though far broader in therapeutic area coverage.
• EMS Pharma: Largest pharmaceutical company in Brazil by volume, with broad generic and hospital injectable offerings. Competes with Samtec in commoditized injectables via national distribution and aggressive public-tender pricing.
• Aché Laboratórios Farmacêuticos: Major Brazilian pharmaceutical company with both branded and generic injectable offerings distributed through hospitals and pharmacies. Comparable in customer channels but broader in therapeutic scope and brand portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/samtec-biotecnologia-ltda

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Samtec Biotecnologia